Please login to the form below

Not currently logged in
Email:
Password:

Sanofi names CSO Gary Nabel to Ebola role

He will serve as response coordinator for the company’s approach to the outbreak.
Gary Nabel

Sanofi has appointed its chief scientific officer Gary Nabel as its Ebola response coordinator.

In the role Nabel will aim to identify how Sanofi can help advance countermeasures to contain the current outbreak and prioritise opportunities to develop novel treatments for the future.

Concerning the role, Nabel said: “Working with out colleagues across the industry, Sanofi is helping to find ways to advance medicines to prevent or treat Ebola virus infection.

“We are also sharing our scientific, medical, regulatory and manufacturing expertise with the World Health Organisation, government and non-governmental organisation – public and private – in an effort to contain this epidemic.”

Over 13,000 cases of Ebola have been confirmed, probable or suspected worldwide and more than 5,000 deaths have been reported.

To date, no licensed treatment has been found but a range of blood, immunological and drug therapies are currently under development, including vaccines from GSK, Merck & Co and Johnson & Johnson.

Elias Zerhouni, president of Sanofi global research and development, said: “Given his past experience in public health epidemics as director of the NIH vaccine research centre and his leadership in developing an Ebola vaccine at NIH, Dr Nabel is uniquely qualified for this position.

“He is working with other organisations, including providing guidance to researchers based on the company's extensive experience in vaccine and drug development, to determine how Sanofi can assist in making progress with this global challenge.”

26th November 2014

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

CBC
Building Europe’s next breakthrough biotechs
Start Codon's Daniel Rooke on fostering biotech success in Cambridge, UK...
Tactful screening & participant sensitivity
Screening participants can involve asking personal questions that could be perceived as intrusive. Here CMR explores the implications of such lines of questioning....
Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...

Infographics